Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol

INTRODUCTION: The immune system is implicated in the aetiology and progression of Parkinson’s disease (PD). Inflammation and immune activation occur both in the brain and in the periphery, and a proinflammatory cytokine profile is associated with more rapid clinical progression. Furthermore, the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenland, Julia C, Cutting, Emma, Kadyan, Sonakshi, Bond, Simon, Chhabra, Anita, Williams-Gray, Caroline H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684836/
https://www.ncbi.nlm.nih.gov/pubmed/33234645
http://dx.doi.org/10.1136/bmjopen-2020-040527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684836/
https://www.ncbi.nlm.nih.gov/pubmed/33234645
http://dx.doi.org/10.1136/bmjopen-2020-040527

Ejemplares similares